Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
NATIONAL INSTITUTES OF HEALTH has floated a tender for Neuronext Clinical Trials (U01 Clinical Trial Optional). The project location is USA and the tender is closing on 05 Mar 2024. The tender notice number is PAR-21-223, while the TOT Ref Number is 52847004. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Neuronext Clinical Trials (U01 Clinical Trial Optional)
Deadline : 05 Mar 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 52847004
Document Ref. No. : PAR-21-223
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Tender are invited for NeuroNEXT Clinical Trials (U01 Clinical Trial Optional)
CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Mar 05, 2024
Posted Date : May 05, 2021
Description: This FOA encourages applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies. Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). Successful applicants will be given access to the NeuroNEXT infrastructure. Following peer review, NINDS will prioritize and order trials that are given access to the NeuroNEXT infrastructure. The NeuroNEXT Clinical Coordinating Center (CCC) will work with the successful applicant to efficiently implement the proposed study. The NeuroNEXT Data Coordinating Center (DCC) will provide statistical and data management support. The NeuroNEXT clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol. Applicants do not need to be part of the existing NeuroNEXT infrastructure.
Documents
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google